Cargando…

High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland

INTRODUCTION: The incidence of hepatitis E virus (HEV) infections in Poland is largely unknown. This study aimed to describe seroprevalence of markers of HEV infection among patients with immunodeficiency of diverse etiology and patients with advanced chronic liver diseases. MATERIAL AND METHODS: Fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parfieniuk-Kowerda, Anna, Jaroszewicz, Jerzy, Łapiński, Tadeusz W., Łucejko, Mariusz, Maciaszek, Magdalena, Świderska, Magdalena, Grzeszczuk, Anna, Naumnik, Beata, Rowiński, Mirosław, Flisiak, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130492/ https://www.ncbi.nlm.nih.gov/pubmed/34025837 http://dx.doi.org/10.5114/aoms.2018.79958

Ejemplares similares

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2019)

The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation
por: Łapiński, Tadeusz W., et al.
Publicado: (2016)

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2015)

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland
por: Grzeszczuk, Anna, et al.
Publicado: (2015)

Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland
por: Pazgan-Simon, Monika, et al.
Publicado: (2023)

The Role of Th17 Response in COVID-19
por: Martonik, Diana, et al.
Publicado: (2021)

Effect of psoriasis activity on serum adiponectin and leptin levels
por: Baran, Anna, et al.
Publicado: (2015)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

Distribution of HBV genotypes in Poland
por: Świderska, Magdalena, et al.
Publicado: (2015)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2021)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19
por: Martonik, Diana, et al.
Publicado: (2023)

Shear-wave elastography for evaluation of hepatic stiffness in chronic viral hepatitis B and C
por: Martonik, Diana, et al.
Publicado: (2023)

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2020)

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2021)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C
por: Rogalska-Taranta, Magdalena, et al.
Publicado: (2017)

Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C
por: Jelski, Wojciech, et al.
Publicado: (2016)

Searching for the optimal population for hepatitis C virus screening in Poland
por: Piekarska, Anna, et al.
Publicado: (2020)

Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study)
por: Czupryna, Piotr, et al.
Publicado: (2022)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2021)

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
por: Brzdęk, Michał, et al.
Publicado: (2023)

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
por: Krahel, Julita Anna, et al.
Publicado: (2020)

Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy
por: Flisiak, Robert, et al.
Publicado: (2021)

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
por: Kiluk, Paulina, et al.
Publicado: (2019)

Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results
por: Kiluk, Paulina, et al.
Publicado: (2021)

Gold Mine Wooden Artefacts: Multianalytical Investigations for the Selection of Appropriate Consolidation Treatments
por: Fejfer, Mariusz, et al.
Publicado: (2022)

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
por: Flisiak, Robert, et al.
Publicado: (2021)

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study
por: Baran, Anna, et al.
Publicado: (2020)

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

Neoehrlichia mikurensis—A New Emerging Tick-Borne Pathogen in North-Eastern Poland?
por: Szczotko, Magdalena, et al.
Publicado: (2023)

Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
por: Dybowska, Dorota, et al.
Publicado: (2023)

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study
por: Simon, Krzysztof Adam, et al.
Publicado: (2019)

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
por: Baran, Anna, et al.
Publicado: (2020)

Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis
por: Baran, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jeoi5vudupptoidf1hqbnv01oa